Bio News
The U.S. National Eye Institute (NEI) confirmed the effects of a 5:1 combination of lutein and zeaxanthin in a clinical trial involving 4203 participants. Taking 10 mg of lutein and 2 mg of zeaxanthin daily increased macular pigment density and lowered the risk of progression to late-stage age-related macular degeneration by approximately 18% to 26%. Free-form ingredients have 3 to 5 times higher absorption rates than esterified forms, making this a key criterion when selecting products.
BIOBOOK TEAM
biobookmedia@biobook.co.krMerck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”
CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
MFDS Begins Distribution of Internationally Certified Reference Materials, Including 24 New Items, for a Total of 882
Ministry of Trade, Industry and Energy signs agreement to promote biotech and medical devices in Gangwon; site visit set for the 14th
RDA develops technology to produce anti-inflammatory exosomes for pets and files patent application
Merck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”
CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
